Industry Research Reports

Home > Reports > Pharma & Healthcare > Bulk Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Bulk Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-24

Pages: 156 Pages

Report ld: 2336456

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

The global market for Bulk Drug was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Bulk Drug, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Bulk Drug by region & country, by Type, and by Application.

The Bulk Drug market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bulk Drug.

Market Segmentation

Report Metric
Details
Report Title
Bulk Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Bulk Drug Companies Covered
Teva, Novartis, Pfizer, Johnson & Johnson, Mylan, North China Pharmaceutical Group, Dr. Reddy’s Laboratories, Roche, Aurobindo pharma, Sun Pharmaceutical Industries, Boehringer Ingelheim GmbH, Bayer, BASF, DSM, Zhejiang Medicine, Biocon, Johnson Matthey, Hisun Pharmacy, Cambrex, Shandong Xinhua Pharmaceutical, Lonza group, Huahai Pharmaceutical, Haerbin Pharmaceutical Group
Global Bulk Drug Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bulk Drug Market, Segment by Type
Antibiotics

Sulpha Drugs

Vitamins,

Steroids

Analgesics

Others
Global Bulk Drug Market, Segment by Application
Hospitals

Clinics

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Bulk Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Bulk Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Bulk Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 Bulk Drug Product Introduction
    1.2 Global Bulk Drug Market Size Forecast
        1.2.1 Global Bulk Drug Sales Value (2019-2030)
        1.2.2 Global Bulk Drug Sales Volume (2019-2030)
        1.2.3 Global Bulk Drug Sales Price (2019-2030)
    1.3 Bulk Drug Market Trends & Drivers
        1.3.1 Bulk Drug Industry Trends
        1.3.2 Bulk Drug Market Drivers & Opportunity
        1.3.3 Bulk Drug Market Challenges
        1.3.4 Bulk Drug Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Bulk Drug Players Revenue Ranking (2023)
    2.2 Global Bulk Drug Revenue by Company (2019-2024)
    2.3 Global Bulk Drug Players Sales Volume Ranking (2023)
    2.4 Global Bulk Drug Sales Volume by Company Players (2019-2024)
    2.5 Global Bulk Drug Average Price by Company (2019-2024)
    2.6 Key Manufacturers Bulk Drug Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Bulk Drug Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Bulk Drug
    2.9 Bulk Drug Market Competitive Analysis
        2.9.1 Bulk Drug Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Bulk Drug Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bulk Drug as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Antibiotics
        3.1.2 Sulpha Drugs
        3.1.3 Vitamins,
        3.1.4 Steroids
        3.1.5 Analgesics
        3.1.6 Others
    3.2 Global Bulk Drug Sales Value by Type
        3.2.1 Global Bulk Drug Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Bulk Drug Sales Value, by Type (2019-2030)
        3.2.3 Global Bulk Drug Sales Value, by Type (%) (2019-2030)
    3.3 Global Bulk Drug Sales Volume by Type
        3.3.1 Global Bulk Drug Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Bulk Drug Sales Volume, by Type (2019-2030)
        3.3.3 Global Bulk Drug Sales Volume, by Type (%) (2019-2030)
    3.4 Global Bulk Drug Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospitals
        4.1.2 Clinics
        4.1.3 Others
    4.2 Global Bulk Drug Sales Value by Application
        4.2.1 Global Bulk Drug Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Bulk Drug Sales Value, by Application (2019-2030)
        4.2.3 Global Bulk Drug Sales Value, by Application (%) (2019-2030)
    4.3 Global Bulk Drug Sales Volume by Application
        4.3.1 Global Bulk Drug Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Bulk Drug Sales Volume, by Application (2019-2030)
        4.3.3 Global Bulk Drug Sales Volume, by Application (%) (2019-2030)
    4.4 Global Bulk Drug Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Bulk Drug Sales Value by Region
        5.1.1 Global Bulk Drug Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Bulk Drug Sales Value by Region (2019-2024)
        5.1.3 Global Bulk Drug Sales Value by Region (2025-2030)
        5.1.4 Global Bulk Drug Sales Value by Region (%), (2019-2030)
    5.2 Global Bulk Drug Sales Volume by Region
        5.2.1 Global Bulk Drug Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Bulk Drug Sales Volume by Region (2019-2024)
        5.2.3 Global Bulk Drug Sales Volume by Region (2025-2030)
        5.2.4 Global Bulk Drug Sales Volume by Region (%), (2019-2030)
    5.3 Global Bulk Drug Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Bulk Drug Sales Value, 2019-2030
        5.4.2 North America Bulk Drug Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Bulk Drug Sales Value, 2019-2030
        5.5.2 Europe Bulk Drug Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Bulk Drug Sales Value, 2019-2030
        5.6.2 Asia Pacific Bulk Drug Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Bulk Drug Sales Value, 2019-2030
        5.7.2 South America Bulk Drug Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Bulk Drug Sales Value, 2019-2030
        5.8.2 Middle East & Africa Bulk Drug Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Bulk Drug Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Bulk Drug Sales Value
        6.2.1 Key Countries/Regions Bulk Drug Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Bulk Drug Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Bulk Drug Sales Value, 2019-2030
        6.3.2 United States Bulk Drug Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Bulk Drug Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Bulk Drug Sales Value, 2019-2030
        6.4.2 Europe Bulk Drug Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Bulk Drug Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Bulk Drug Sales Value, 2019-2030
        6.5.2 China Bulk Drug Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Bulk Drug Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Bulk Drug Sales Value, 2019-2030
        6.6.2 Japan Bulk Drug Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Bulk Drug Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Bulk Drug Sales Value, 2019-2030
        6.7.2 South Korea Bulk Drug Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Bulk Drug Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Bulk Drug Sales Value, 2019-2030
        6.8.2 Southeast Asia Bulk Drug Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Bulk Drug Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Bulk Drug Sales Value, 2019-2030
        6.9.2 India Bulk Drug Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Bulk Drug Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Teva
        7.1.1 Teva Company Information
        7.1.2 Teva Introduction and Business Overview
        7.1.3 Teva Bulk Drug Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Teva Bulk Drug Product Offerings
        7.1.5 Teva Recent Development
    7.2 Novartis
        7.2.1 Novartis Company Information
        7.2.2 Novartis Introduction and Business Overview
        7.2.3 Novartis Bulk Drug Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Novartis Bulk Drug Product Offerings
        7.2.5 Novartis Recent Development
    7.3 Pfizer
        7.3.1 Pfizer Company Information
        7.3.2 Pfizer Introduction and Business Overview
        7.3.3 Pfizer Bulk Drug Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Pfizer Bulk Drug Product Offerings
        7.3.5 Pfizer Recent Development
    7.4 Johnson & Johnson
        7.4.1 Johnson & Johnson Company Information
        7.4.2 Johnson & Johnson Introduction and Business Overview
        7.4.3 Johnson & Johnson Bulk Drug Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Johnson & Johnson Bulk Drug Product Offerings
        7.4.5 Johnson & Johnson Recent Development
    7.5 Mylan
        7.5.1 Mylan Company Information
        7.5.2 Mylan Introduction and Business Overview
        7.5.3 Mylan Bulk Drug Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Mylan Bulk Drug Product Offerings
        7.5.5 Mylan Recent Development
    7.6 North China Pharmaceutical Group
        7.6.1 North China Pharmaceutical Group Company Information
        7.6.2 North China Pharmaceutical Group Introduction and Business Overview
        7.6.3 North China Pharmaceutical Group Bulk Drug Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 North China Pharmaceutical Group Bulk Drug Product Offerings
        7.6.5 North China Pharmaceutical Group Recent Development
    7.7 Dr. Reddy’s Laboratories
        7.7.1 Dr. Reddy’s Laboratories Company Information
        7.7.2 Dr. Reddy’s Laboratories Introduction and Business Overview
        7.7.3 Dr. Reddy’s Laboratories Bulk Drug Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Dr. Reddy’s Laboratories Bulk Drug Product Offerings
        7.7.5 Dr. Reddy’s Laboratories Recent Development
    7.8 Roche
        7.8.1 Roche Company Information
        7.8.2 Roche Introduction and Business Overview
        7.8.3 Roche Bulk Drug Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Roche Bulk Drug Product Offerings
        7.8.5 Roche Recent Development
    7.9 Aurobindo pharma
        7.9.1 Aurobindo pharma Company Information
        7.9.2 Aurobindo pharma Introduction and Business Overview
        7.9.3 Aurobindo pharma Bulk Drug Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Aurobindo pharma Bulk Drug Product Offerings
        7.9.5 Aurobindo pharma Recent Development
    7.10 Sun Pharmaceutical Industries
        7.10.1 Sun Pharmaceutical Industries Company Information
        7.10.2 Sun Pharmaceutical Industries Introduction and Business Overview
        7.10.3 Sun Pharmaceutical Industries Bulk Drug Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 Sun Pharmaceutical Industries Bulk Drug Product Offerings
        7.10.5 Sun Pharmaceutical Industries Recent Development
    7.11 Boehringer Ingelheim GmbH
        7.11.1 Boehringer Ingelheim GmbH Company Information
        7.11.2 Boehringer Ingelheim GmbH Introduction and Business Overview
        7.11.3 Boehringer Ingelheim GmbH Bulk Drug Sales, Revenue and Gross Margin (2019-2024)
        7.11.4 Boehringer Ingelheim GmbH Bulk Drug Product Offerings
        7.11.5 Boehringer Ingelheim GmbH Recent Development
    7.12 Bayer
        7.12.1 Bayer Company Information
        7.12.2 Bayer Introduction and Business Overview
        7.12.3 Bayer Bulk Drug Sales, Revenue and Gross Margin (2019-2024)
        7.12.4 Bayer Bulk Drug Product Offerings
        7.12.5 Bayer Recent Development
    7.13 BASF
        7.13.1 BASF Company Information
        7.13.2 BASF Introduction and Business Overview
        7.13.3 BASF Bulk Drug Sales, Revenue and Gross Margin (2019-2024)
        7.13.4 BASF Bulk Drug Product Offerings
        7.13.5 BASF Recent Development
    7.14 DSM
        7.14.1 DSM Company Information
        7.14.2 DSM Introduction and Business Overview
        7.14.3 DSM Bulk Drug Sales, Revenue and Gross Margin (2019-2024)
        7.14.4 DSM Bulk Drug Product Offerings
        7.14.5 DSM Recent Development
    7.15 Zhejiang Medicine
        7.15.1 Zhejiang Medicine Company Information
        7.15.2 Zhejiang Medicine Introduction and Business Overview
        7.15.3 Zhejiang Medicine Bulk Drug Sales, Revenue and Gross Margin (2019-2024)
        7.15.4 Zhejiang Medicine Bulk Drug Product Offerings
        7.15.5 Zhejiang Medicine Recent Development
    7.16 Biocon
        7.16.1 Biocon Company Information
        7.16.2 Biocon Introduction and Business Overview
        7.16.3 Biocon Bulk Drug Sales, Revenue and Gross Margin (2019-2024)
        7.16.4 Biocon Bulk Drug Product Offerings
        7.16.5 Biocon Recent Development
    7.17 Johnson Matthey
        7.17.1 Johnson Matthey Company Information
        7.17.2 Johnson Matthey Introduction and Business Overview
        7.17.3 Johnson Matthey Bulk Drug Sales, Revenue and Gross Margin (2019-2024)
        7.17.4 Johnson Matthey Bulk Drug Product Offerings
        7.17.5 Johnson Matthey Recent Development
    7.18 Hisun Pharmacy
        7.18.1 Hisun Pharmacy Company Information
        7.18.2 Hisun Pharmacy Introduction and Business Overview
        7.18.3 Hisun Pharmacy Bulk Drug Sales, Revenue and Gross Margin (2019-2024)
        7.18.4 Hisun Pharmacy Bulk Drug Product Offerings
        7.18.5 Hisun Pharmacy Recent Development
    7.19 Cambrex
        7.19.1 Cambrex Company Information
        7.19.2 Cambrex Introduction and Business Overview
        7.19.3 Cambrex Bulk Drug Sales, Revenue and Gross Margin (2019-2024)
        7.19.4 Cambrex Bulk Drug Product Offerings
        7.19.5 Cambrex Recent Development
    7.20 Shandong Xinhua Pharmaceutical
        7.20.1 Shandong Xinhua Pharmaceutical Company Information
        7.20.2 Shandong Xinhua Pharmaceutical Introduction and Business Overview
        7.20.3 Shandong Xinhua Pharmaceutical Bulk Drug Sales, Revenue and Gross Margin (2019-2024)
        7.20.4 Shandong Xinhua Pharmaceutical Bulk Drug Product Offerings
        7.20.5 Shandong Xinhua Pharmaceutical Recent Development
    7.21 Lonza group
        7.21.1 Lonza group Company Information
        7.21.2 Lonza group Introduction and Business Overview
        7.21.3 Lonza group Bulk Drug Sales, Revenue and Gross Margin (2019-2024)
        7.21.4 Lonza group Bulk Drug Product Offerings
        7.21.5 Lonza group Recent Development
    7.22 Huahai Pharmaceutical
        7.22.1 Huahai Pharmaceutical Company Information
        7.22.2 Huahai Pharmaceutical Introduction and Business Overview
        7.22.3 Huahai Pharmaceutical Bulk Drug Sales, Revenue and Gross Margin (2019-2024)
        7.22.4 Huahai Pharmaceutical Bulk Drug Product Offerings
        7.22.5 Huahai Pharmaceutical Recent Development
    7.23 Haerbin Pharmaceutical Group
        7.23.1 Haerbin Pharmaceutical Group Company Information
        7.23.2 Haerbin Pharmaceutical Group Introduction and Business Overview
        7.23.3 Haerbin Pharmaceutical Group Bulk Drug Sales, Revenue and Gross Margin (2019-2024)
        7.23.4 Haerbin Pharmaceutical Group Bulk Drug Product Offerings
        7.23.5 Haerbin Pharmaceutical Group Recent Development

 8 Industry Chain Analysis
    8.1 Bulk Drug Industrial Chain
    8.2 Bulk Drug Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Bulk Drug Sales Model
        8.5.2 Sales Channel
        8.5.3 Bulk Drug Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Bulk Drug Market Trends
    Table 2. Bulk Drug Market Drivers & Opportunity
    Table 3. Bulk Drug Market Challenges
    Table 4. Bulk Drug Market Restraints
    Table 5. Global Bulk Drug Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Bulk Drug Revenue Market Share by Company (2019-2024)
    Table 7. Global Bulk Drug Sales Volume by Company (2019-2024) & (K MT)
    Table 8. Global Bulk Drug Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Bulk Drug Price by Company (2019-2024) & (USD/MT)
    Table 10. Key Manufacturers Bulk Drug Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Bulk Drug Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Bulk Drug
    Table 13. Global Bulk Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bulk Drug as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Bulk Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Bulk Drug Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Bulk Drug Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Bulk Drug Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Bulk Drug Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Bulk Drug Sales Volume by Type: 2019 VS 2023 VS 2030 (K MT)
    Table 22. Global Bulk Drug Sales Volume by Type (2019-2024) & (K MT)
    Table 23. Global Bulk Drug Sales Volume by Type (2025-2030) & (K MT)
    Table 24. Global Bulk Drug Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Bulk Drug Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Bulk Drug Price by Type (2019-2024) & (USD/MT)
    Table 27. Global Bulk Drug Price by Type (2025-2030) & (USD/MT)
    Table 28. Global Bulk Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Bulk Drug Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Bulk Drug Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Bulk Drug Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Bulk Drug Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Bulk Drug Sales Volume by Application: 2019 VS 2023 VS 2030 (K MT)
    Table 34. Global Bulk Drug Sales Volume by Application (2019-2024) & (K MT)
    Table 35. Global Bulk Drug Sales Volume by Application (2025-2030) & (K MT)
    Table 36. Global Bulk Drug Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Bulk Drug Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Bulk Drug Price by Application (2019-2024) & (USD/MT)
    Table 39. Global Bulk Drug Price by Application (2025-2030) & (USD/MT)
    Table 40. Global Bulk Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Bulk Drug Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Bulk Drug Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Bulk Drug Sales Value by Region (2019-2024) & (%)
    Table 44. Global Bulk Drug Sales Value by Region (2025-2030) & (%)
    Table 45. Global Bulk Drug Sales Volume by Region (K MT): 2019 VS 2023 VS 2030
    Table 46. Global Bulk Drug Sales Volume by Region (2019-2024) & (K MT)
    Table 47. Global Bulk Drug Sales Volume by Region (2025-2030) & (K MT)
    Table 48. Global Bulk Drug Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Bulk Drug Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Bulk Drug Average Price by Region (2019-2024) & (USD/MT)
    Table 51. Global Bulk Drug Average Price by Region (2025-2030) & (USD/MT)
    Table 52. Key Countries/Regions Bulk Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Bulk Drug Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Bulk Drug Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Bulk Drug Sales Volume, (2019-2024) & (K MT)
    Table 56. Key Countries/Regions Bulk Drug Sales Volume, (2025-2030) & (K MT)
    Table 57. Teva Company Information
    Table 58. Teva Introduction and Business Overview
    Table 59. Teva Bulk Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 60. Teva Bulk Drug Product Offerings
    Table 61. Teva Recent Development
    Table 62. Novartis Company Information
    Table 63. Novartis Introduction and Business Overview
    Table 64. Novartis Bulk Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 65. Novartis Bulk Drug Product Offerings
    Table 66. Novartis Recent Development
    Table 67. Pfizer Company Information
    Table 68. Pfizer Introduction and Business Overview
    Table 69. Pfizer Bulk Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 70. Pfizer Bulk Drug Product Offerings
    Table 71. Pfizer Recent Development
    Table 72. Johnson & Johnson Company Information
    Table 73. Johnson & Johnson Introduction and Business Overview
    Table 74. Johnson & Johnson Bulk Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 75. Johnson & Johnson Bulk Drug Product Offerings
    Table 76. Johnson & Johnson Recent Development
    Table 77. Mylan Company Information
    Table 78. Mylan Introduction and Business Overview
    Table 79. Mylan Bulk Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 80. Mylan Bulk Drug Product Offerings
    Table 81. Mylan Recent Development
    Table 82. North China Pharmaceutical Group Company Information
    Table 83. North China Pharmaceutical Group Introduction and Business Overview
    Table 84. North China Pharmaceutical Group Bulk Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 85. North China Pharmaceutical Group Bulk Drug Product Offerings
    Table 86. North China Pharmaceutical Group Recent Development
    Table 87. Dr. Reddy’s Laboratories Company Information
    Table 88. Dr. Reddy’s Laboratories Introduction and Business Overview
    Table 89. Dr. Reddy’s Laboratories Bulk Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 90. Dr. Reddy’s Laboratories Bulk Drug Product Offerings
    Table 91. Dr. Reddy’s Laboratories Recent Development
    Table 92. Roche Company Information
    Table 93. Roche Introduction and Business Overview
    Table 94. Roche Bulk Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 95. Roche Bulk Drug Product Offerings
    Table 96. Roche Recent Development
    Table 97. Aurobindo pharma Company Information
    Table 98. Aurobindo pharma Introduction and Business Overview
    Table 99. Aurobindo pharma Bulk Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 100. Aurobindo pharma Bulk Drug Product Offerings
    Table 101. Aurobindo pharma Recent Development
    Table 102. Sun Pharmaceutical Industries Company Information
    Table 103. Sun Pharmaceutical Industries Introduction and Business Overview
    Table 104. Sun Pharmaceutical Industries Bulk Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 105. Sun Pharmaceutical Industries Bulk Drug Product Offerings
    Table 106. Sun Pharmaceutical Industries Recent Development
    Table 107. Boehringer Ingelheim GmbH Company Information
    Table 108. Boehringer Ingelheim GmbH Introduction and Business Overview
    Table 109. Boehringer Ingelheim GmbH Bulk Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 110. Boehringer Ingelheim GmbH Bulk Drug Product Offerings
    Table 111. Boehringer Ingelheim GmbH Recent Development
    Table 112. Bayer Company Information
    Table 113. Bayer Introduction and Business Overview
    Table 114. Bayer Bulk Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 115. Bayer Bulk Drug Product Offerings
    Table 116. Bayer Recent Development
    Table 117. BASF Company Information
    Table 118. BASF Introduction and Business Overview
    Table 119. BASF Bulk Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 120. BASF Bulk Drug Product Offerings
    Table 121. BASF Recent Development
    Table 122. DSM Company Information
    Table 123. DSM Introduction and Business Overview
    Table 124. DSM Bulk Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 125. DSM Bulk Drug Product Offerings
    Table 126. DSM Recent Development
    Table 127. Zhejiang Medicine Company Information
    Table 128. Zhejiang Medicine Introduction and Business Overview
    Table 129. Zhejiang Medicine Bulk Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 130. Zhejiang Medicine Bulk Drug Product Offerings
    Table 131. Zhejiang Medicine Recent Development
    Table 132. Biocon Company Information
    Table 133. Biocon Introduction and Business Overview
    Table 134. Biocon Bulk Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 135. Biocon Bulk Drug Product Offerings
    Table 136. Biocon Recent Development
    Table 137. Johnson Matthey Company Information
    Table 138. Johnson Matthey Introduction and Business Overview
    Table 139. Johnson Matthey Bulk Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 140. Johnson Matthey Bulk Drug Product Offerings
    Table 141. Johnson Matthey Recent Development
    Table 142. Hisun Pharmacy Company Information
    Table 143. Hisun Pharmacy Introduction and Business Overview
    Table 144. Hisun Pharmacy Bulk Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 145. Hisun Pharmacy Bulk Drug Product Offerings
    Table 146. Hisun Pharmacy Recent Development
    Table 147. Cambrex Company Information
    Table 148. Cambrex Introduction and Business Overview
    Table 149. Cambrex Bulk Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 150. Cambrex Bulk Drug Product Offerings
    Table 151. Cambrex Recent Development
    Table 152. Shandong Xinhua Pharmaceutical Company Information
    Table 153. Shandong Xinhua Pharmaceutical Introduction and Business Overview
    Table 154. Shandong Xinhua Pharmaceutical Bulk Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 155. Shandong Xinhua Pharmaceutical Bulk Drug Product Offerings
    Table 156. Shandong Xinhua Pharmaceutical Recent Development
    Table 157. Lonza group Company Information
    Table 158. Lonza group Introduction and Business Overview
    Table 159. Lonza group Bulk Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 160. Lonza group Bulk Drug Product Offerings
    Table 161. Lonza group Recent Development
    Table 162. Huahai Pharmaceutical Company Information
    Table 163. Huahai Pharmaceutical Introduction and Business Overview
    Table 164. Huahai Pharmaceutical Bulk Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 165. Huahai Pharmaceutical Bulk Drug Product Offerings
    Table 166. Huahai Pharmaceutical Recent Development
    Table 167. Haerbin Pharmaceutical Group Company Information
    Table 168. Haerbin Pharmaceutical Group Introduction and Business Overview
    Table 169. Haerbin Pharmaceutical Group Bulk Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 170. Haerbin Pharmaceutical Group Bulk Drug Product Offerings
    Table 171. Haerbin Pharmaceutical Group Recent Development
    Table 172. Key Raw Materials Lists
    Table 173. Raw Materials Key Suppliers Lists
    Table 174. Bulk Drug Downstream Customers
    Table 175. Bulk Drug Distributors List
    Table 176. Research Programs/Design for This Report
    Table 177. Key Data Information from Secondary Sources
    Table 178. Key Data Information from Primary Sources
List of Figures
    Figure 1. Bulk Drug Product Picture
    Figure 2. Global Bulk Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Bulk Drug Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Bulk Drug Sales Volume (2019-2030) & (K MT)
    Figure 5. Global Bulk Drug Sales Price (2019-2030) & (USD/MT)
    Figure 6. Bulk Drug Report Years Considered
    Figure 7. Global Bulk Drug Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Bulk Drug Players Sales Volume Ranking (2023) & (K MT)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Bulk Drug Revenue in 2023
    Figure 10. Bulk Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Antibiotics Picture
    Figure 12. Sulpha Drugs Picture
    Figure 13. Vitamins, Picture
    Figure 14. Steroids Picture
    Figure 15. Analgesics Picture
    Figure 16. Others Picture
    Figure 17. Global Bulk Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Bulk Drug Sales Value Market Share by Type, 2023 & 2030
    Figure 19. Global Bulk Drug Sales Volume by Type (2019 VS 2023 VS 2030) & (K MT)
    Figure 20. Global Bulk Drug Sales Volume Market Share by Type, 2023 & 2030
    Figure 21. Global Bulk Drug Price by Type (2019-2030) & (USD/MT)
    Figure 22. Product Picture of Hospitals
    Figure 23. Product Picture of Clinics
    Figure 24. Product Picture of Others
    Figure 25. Global Bulk Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 26. Global Bulk Drug Sales Value Market Share by Application, 2023 & 2030
    Figure 27. Global Bulk Drug Sales Volume by Application (2019 VS 2023 VS 2030) & (K MT)
    Figure 28. Global Bulk Drug Sales Volume Market Share by Application, 2023 & 2030
    Figure 29. Global Bulk Drug Price by Application (2019-2030) & (USD/MT)
    Figure 30. North America Bulk Drug Sales Value (2019-2030) & (US$ Million)
    Figure 31. North America Bulk Drug Sales Value by Country (%), 2023 VS 2030
    Figure 32. Europe Bulk Drug Sales Value (2019-2030) & (US$ Million)
    Figure 33. Europe Bulk Drug Sales Value by Country (%), 2023 VS 2030
    Figure 34. Asia Pacific Bulk Drug Sales Value (2019-2030) & (US$ Million)
    Figure 35. Asia Pacific Bulk Drug Sales Value by Country (%), 2023 VS 2030
    Figure 36. South America Bulk Drug Sales Value (2019-2030) & (US$ Million)
    Figure 37. South America Bulk Drug Sales Value by Country (%), 2023 VS 2030
    Figure 38. Middle East & Africa Bulk Drug Sales Value (2019-2030) & (US$ Million)
    Figure 39. Middle East & Africa Bulk Drug Sales Value by Country (%), 2023 VS 2030
    Figure 40. Key Countries/Regions Bulk Drug Sales Value (%), (2019-2030)
    Figure 41. Key Countries/Regions Bulk Drug Sales Volume (%), (2019-2030)
    Figure 42. United States Bulk Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 43. United States Bulk Drug Sales Value by Type (%), 2023 VS 2030
    Figure 44. United States Bulk Drug Sales Value by Application (%), 2023 VS 2030
    Figure 45. Europe Bulk Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Europe Bulk Drug Sales Value by Type (%), 2023 VS 2030
    Figure 47. Europe Bulk Drug Sales Value by Application (%), 2023 VS 2030
    Figure 48. China Bulk Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 49. China Bulk Drug Sales Value by Type (%), 2023 VS 2030
    Figure 50. China Bulk Drug Sales Value by Application (%), 2023 VS 2030
    Figure 51. Japan Bulk Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 52. Japan Bulk Drug Sales Value by Type (%), 2023 VS 2030
    Figure 53. Japan Bulk Drug Sales Value by Application (%), 2023 VS 2030
    Figure 54. South Korea Bulk Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 55. South Korea Bulk Drug Sales Value by Type (%), 2023 VS 2030
    Figure 56. South Korea Bulk Drug Sales Value by Application (%), 2023 VS 2030
    Figure 57. Southeast Asia Bulk Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 58. Southeast Asia Bulk Drug Sales Value by Type (%), 2023 VS 2030
    Figure 59. Southeast Asia Bulk Drug Sales Value by Application (%), 2023 VS 2030
    Figure 60. India Bulk Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 61. India Bulk Drug Sales Value by Type (%), 2023 VS 2030
    Figure 62. India Bulk Drug Sales Value by Application (%), 2023 VS 2030
    Figure 63. Bulk Drug Industrial Chain
    Figure 64. Bulk Drug Manufacturing Cost Structure
    Figure 65. Channels of Distribution (Direct Sales, and Distribution)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed

The global market for Bulk Drug was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Bulk Drug, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Bulk Drug by region & country, by Type, and by Application.

The Bulk Drug market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bulk Drug.

Market Segmentation

Industry: Pharma & Healthcare

Published: 2024-01-24

Pages: 156 Pages

Report ld: 2336456

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 3950.00

Multi Users License

USD 5925.00

Corporate Users License